Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / PEBP1

PEBP1

Basics

Aliases:
This biomarker is also known as:
  • PEBP,
  • prostatic binding protein,
  • RKIP,
  • phosphatidylethanolamine binding protein 1,
  • PEBP-1,
  • Phosphatidylethanolamine-binding protein 1,
  • HCNPpp,
  • Neuropolypeptide h3,
  • hippocampal cholinergic neurostimulating peptide,
  • HCNP,
  • PBP,
  • Prostatic-binding protein,
  • Raf kinase inhibitory protein,

View in BioMuta

Description…

PEBP1 is a cytoplasmic protein that binds ATP, opioids and phosphatidylethanolamine. It has lower affinity for phosphatidylinositol and phosphatidylcholine. PEBP1 is a serine protease inhibitor which inhibits thrombin, neuropsin and chymotrypsin but not trypsin, tissue type plasminogen activator and elastase. PEBP1 may be involved in the function of the presynaptic cholinergic neurons of the central nervous system. PEBP1 increases the production of choline acetyltransferase but not acetylcholinesterase and seems to be mediated by a specific receptor.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: PEBP1

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.
Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.